Mesoblast Ltd
Change company Symbol lookup
Select an option...
MESO Mesoblast Ltd
BAC Bank of America Corp
AZN AstraZeneca PLC
CLZNY Clariant AG
CARR Carrier Global Corp
KBH KB Home
SMIT Schmitt Industries Inc
OOMA Ooma Inc
SEDG Solaredge Technologies Inc
CELH Celsius Holdings Inc
Go

Health Care : Biotechnology | Mid Cap Growth
Based in Australia
Company profile

Mesoblast Limited is engaged in the development of regenerative medicine products. The Company’s regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high and unmet medical needs. The Company’s portfolio of Phase III product candidates comprises RYONCIL (remestemcel-L) for steroid-refractory acute graft versus host disease (acute GVHD), REVASCOR for advanced chronic heart failure (CHF) and MPC-06-ID for chronic low back pain due to degenerative disc disease. The Company's product candidate, MPC-150-IM, is in Phase III trials for the treatment of both advanced and end-stage CHF. The Company has conducted Phase II trial of MPC-300-IV in patients with biologic-refractory rheumatoid arthritis. The Company is developing MPC-25-Osteo for spinal fusion.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$14.93
Day's Change
-0.35 (-2.29%)
Bid
--
Ask
--
B/A Size
--
Day's High
15.38
Day's Low
14.81
Volume
(Light)
Volume:
240,819

10-day average volume:
563,089
240,819
  • Prev Close
    15.28
  • Today's Open
    15.31
  • Day's Range
    14.81-15.38
  • Avg Vol (10-day)
    563.1K
  • Last (time)
    12:59p ET 11/27/20
  • Last (size)
    40
  • 52-Wk Range
    3.12 - 21.28
    LowHigh
  • (03/23/20 - 08/17/20)
    29.84%
  • 151.9%
  • Market Cap
    1.7B
  • Shares Outstanding
    117.2M
  • -0.89
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 3.8
  • 2.22
  • (% of float 11/15/20)
    3.65

Latest News

November 26, 2020
6:20 am ET
Accesswire
November 25, 2020
10:22 pm ET
Globe Newswire
11:37 am ET
Accesswire
11:00 am ET
Globe Newswire
7:04 am ET
Globe Newswire
November 24, 2020
8:29 pm ET
Newsfile
4:25 pm ET
Accesswire
4:00 pm ET
Globe Newswire
1:40 pm ET
Accesswire
12:01 pm ET
Accesswire
11:30 am ET
Globe Newswire
6:21 am ET
Accesswire
November 23, 2020
1:28 pm ET
Newsfile
12:00 pm ET
Globe Newswire
11:45 am ET
Accesswire
6:26 am ET
Newsfile
November 22, 2020
12:31 am ET
Globe Newswire
November 20, 2020
7:06 pm ET
Newsfile
November 19, 2020
5:43 pm ET
Accesswire
5:36 pm ET
Globe Newswire
5:21 pm ET
Globe Newswire
5:11 pm ET
Globe Newswire
4:19 pm ET
Globe Newswire
6:21 am ET
Accesswire
November 18, 2020
9:45 pm ET
Newsfile
9:26 pm ET
Accesswire
7:42 pm ET
Globe Newswire
5:52 pm ET
Accesswire
5:00 pm ET
Globe Newswire
11:52 am ET
Globe Newswire
11:33 am ET
Accesswire
November 17, 2020
5:12 pm ET
Accesswire
3:45 pm ET
Newsfile
12:00 pm ET
Accesswire
11:45 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.